[NMS Pediatrics (National Medical Series For Independent Study) Download
Amancio Mccrae
This program supports research career development for pediatricians who are commencing basic science research relevant to the field of pediatrics. Please note that projects proposing patient-oriented research are not eligible for this opportunity.
NMS Pediatrics (National Medical Series for Independent Study) download
Download File ✪ https://t.co/awWWy1HXwA
6) Plans for Extramural Funding: K12 Scholars are encouraged and expected to apply for independent research grant support during the period of K12 support (e.g., K08, R01). Funding goals should be outlined in the application including timing of and type of NIH or equivalent independent support that will be sought. This can either be a resubmission of a previously reviewed but unfunded application or a new application.
7) Institutional Support: The division director or departmental chairman of each applicant for this K12 grant will be specifically involved in approving the K12 grant application, confirming 75% protected research time for the applicant and divisional cost share of any salary and fringe expenses that exceed the $100,000 provided by the grant, and ensuring that the extramural grant application is submitted as proposed in the K12 grant application.
Items that may NOT be supported within the $25,000 support category include: mentor salary support; direct support of the laboratories, travel, and research projects of the investigators serving as mentors beyond those expenses directly attributable to the scholar's project
*NOTE: The Candidate Information Section and the Research Strategy section together must not exceed 12 pages (white space at the end of each section is not counted). If the text exceeds 12 pages for these two sections, your application will be returned without review.
10) Vertebrate Animals Section (if applicable) - The Vertebrate Animals Section is a standalone document and must include enough procedural details for evaluation even if these details are included elsewhere in the grant application, publications, IACUC protocol, or institutional SOPs/guidelines. The details should include:
11) Response to Prior Reviews - If the research project has previously been submitted for consideration to an institutional K mechanism (including this K12 opportunity) or for extramural funding, the applicant should include a copy of the critique from the prior submission and within a 1 page limit, indicate how the criticisms will be addressed by the new work funded by this K12 grant submission.
12) Letters of Suport - Letters of support can be used to reinforce attributes of the proposed work, team of investigators, mentorship and institutional resources/leadership. They can also be used to highlight a contribution of a research resource or material that is unique and/or essential to the successful completion of the proposed research. Letters of support are not required.
The NICHD-funded Child Health Research Career Development (K12) Awards are specifically designed to prepare pediatricians for careers in basic science investigation relevant to childhood illnesses. While clinical research careers are equally valued by our leadership and institutions, this particular K12 program is not designed to support clinical research careers. Below are specific citations from the RFA that provide evidence of this focus:
Stated Purpose
The National Institute of Child Health and Human Development (NICHD) supports a program of Child Health Research Career Development Awards (CHRCDA) intended to develop resources to speed the transfer of knowledge gained through studies in basic science to clinical applications that will benefit the health of children. The CHRCDA supports research career development of pediatricians who have recently completed subspecialty training and who are commencing basic research training relevant to child health. The goal of this initiative is to advance research in child health and to support educational institutions in their ability to stimulate novel research initiatives and career development experiences for junior investigators. This is accomplished by increasing the number and effectiveness of established pediatric investigators who have a grounding in basic science and research skills that can be applied to the health problems of children, as well as by increasing the number of pediatric medical centers that can stimulate and facilitate the application of research findings to pressing pediatric problems.
What other career development opportunities are available to pediatrician physician scientists at Emory University?
The APSP K12 focuses exclusively on training pediatric scientists engaged in basic research. This complements yet does not overlap with the existing Georgia CTSA KL2 Scholars Program, whose focus is expressly on clinical and translational career development for MD clinician scientists and PhD translational scientists and is available for all disciplines, pediatric or adult, across multiple partner institutions. Although separate programs, the APSP successfully leverages the Georgia CTSA career development infrastructure and didactic course offerings such as MSCR 594M - Scientific and Grant Writing, and MSCR 761M - Introduction to Clinical and Translational Research. The K-Club and internal pilot awards programs provide additional career development options for all junior health scientists at Emory.
It is critical that we recruit new faculty into the Atlanta Pediatric Scholars Program who are pursuing basic science careers and who will be very productive during and after training. The program is judged by the success of its scholars, including by the quality and quantity of their publications and especially by their ability to obtain independent NIH grants. The reviewers for our renewal application will assess specific criteria outlined in the goals of the program. The best scenario is that we will be able to show a number of trainees who have become R01 (potentially K08) funded in their area of research and who are producing high quality publications that demonstrate high productivity and independence.
This four-year special residency program, sponsored jointly by the Department of Medicine and Pediatrics, was established in the early 1980s. During the four years, residents participate in the basic services, continuity practices and electives of the two departments. Upon completion, Med-Peds physicians are eligible for board certification in both specialties.
We encourage resident involvement on a wide variety of hospital and university committees as well as national organizations. Here are a few examples of additional opportunities within our program and university.
Comprised of Pediatric and Med/Peds residents who are elected by their peers, the members of this council act as liaisons between the residents and the Office of Medical Education (OME). These residents meet with the chief residents monthly, where they bring feedback from their fellow residents to the attention of the chief residents and program director. They directly participate in problem solving of any issues that arise during these meetings and also help relay important information from the OME to the residents.
The Infection Control Committee is responsible for implementing the hospital infection control program. This includes the review and analysis of nosocomial infections and infection potentials, the promotion of a preventative and corrective program designed to minimize infection hazards and the supervision of infection control in all phases of the hospitals' activities. The infection Control Program shall be designed to meet or exceed the current national standards in hospital infection control.
Serve in an advisory capacity to the Medical Staff and hospital Administration in all matters pertaining to the use of drugs, including investigational drugs. Develop the formulary of drugs accepted for use in this hospital and provide for its constant revision. Establish suitable educational programs for this hospital's professional staff on matters relating to drug use. Study problems relating to the distribution and administration of medications, including medication incidents. Review adverse drug reactions occurring in the hospital. Advise the Pharmacy in the Implementation and review of drug distribution and control procedures. Reviews the appropriateness, safety and effectiveness of the empiric, therapeutic and prophylactic use of all drugs determined by assigned members of the Medical Staff to be pertinent to the age population that the hospital services. Evaluate and approve protocols concerning the use of investigational drugs.
This committee reviews all "Code 300" events and Rapid Response Team calls. The committee determines if the action taken was appropriate. The committee assesses the circumstances surrounding the event and determines if a further Root Cause Analysis is necessary. The committee also reviews all policies, procedures and equipment involved in Code 300 or Rapid Response Team events.
This committee is composed of physicians, nurses, and administrative representatives from diverse backgrounds and specialties. The members of the Reaching for Zero team have significant responsibility in moving patient safety and outcomes initiatives forward. This committee develops an agenda and solutions to help improve service.
Offer confidential case review and non-binding recommendations for clinical situations in which family, staff or physicians are in conflict. Request for case review may be made by any member of the care team, patient or patient's guardian. Attending physician will be notified at time of such request. Provide a forum for review of hospital by-laws and policies and creation of new policy in order to rectify reoccurring conflicts, clarify current procedures and address emerging ethical concerns with the approval of the MEC. Create educational opportunities to allow discussion and review of pertinent ethical issues
795a8134c1